Showing results (511-520 of 537) with videos related to

Sort By:
Pageof 54
Leukemia|August 26, 2006
Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trialU Jehn, S Suciu, X Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trialsL Pagano, A Pulsoni, M Vignetti, et al.
Bone Marrow Transplantation|June 1, 1996
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative GroupsS Keating, S Suciu, T de Witte, et al.
Bone Marrow Transplantation|April 27, 1999
Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemiaW Arcese, C Guglielmi, A P Iori, et al.
Bone Marrow Transplantation|April 21, 2001
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)B Björkstrand, H Svensson, H Goldschmidt, et al.
Cell|May 20, 2009
Essential role for TRPC5 in amygdala function and fear-related behaviorAntonio Riccio, Yan Li, Jisook Moon, et al.
British Journal of Haematology|February 28, 2001
Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemiaL Pagana, A Pulsoni, M E Tosti, et al.
Blood|July 29, 1998
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapyP L Zinzani, M Martelli, M Magagnoli, et al.
Haematologica|December 20, 1999
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?P L Zinzani, M Martelli, M Magagnoli, et al.
Blood|August 15, 2000
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groupsM A Sanz, F Lo Coco, G Martín, et al.
Pageof 54